Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.

Literature DB >> 18422612

Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.

Abstract

Evidence-based guidelines are presented on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. They include details of therapeutic products available in the UK and they update and replace previous United Kingdom Haemophilia Centre Doctors' Organisation guidelines.

Entities: Disease

Mesh：

Substances：

Year: 2008 PMID： 18422612 DOI： 10.1111/j.1365-2516.2008.01695.x

Source DB: PubMed Journal: Haemophilia ISSN： 1351-8216 Impact factor: 4.287

Keyword Cloud
Cited

28 in total

1. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors: Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal: Blood Transfus Date: 2015-12-15 Impact factor: 3.443

Review 10. Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

Authors: Leopold Grillberger; Thomas R Kreil; Sonia Nasr; Manfred Reiter
Journal: Biotechnol J Date: 2009-02 Impact factor: 4.677

Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.

1. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Review 2. Clinical use of factor VIII and factor IX concentrates.

3. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Review 4. Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.

5. Prophylaxis in haemophilia should be life-long.

6. Massive hemoperitoneum due to a ruptured corpus luteum cyst in a patient with congenital hypofibrinogenemia.

7. Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

8. Self-management and skills acquisition in boys with haemophilia.

Review 9. Treatment of congenital fibrinogen deficiency: overview and recent findings.

Review 10. Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.